| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |